Literature DB >> 7491648

Central benzodiazepine receptor distribution after subcortical hemorrhage evaluated by means of [123I]iomazenil and SPECT.

J Hatazawa1, E Shimosegawa, T Satoh, I Kanno, K Uemura.   

Abstract

BACKGROUND AND
PURPOSE: [123I]Iomazenil is a single-photon emission computed tomography (SPECT) tracer that selectively binds to central benzodiazepine receptor in the neuron membrane. With this ligand, we studied the central benzodiazepine receptor distribution in the cortex remote from subcortical hematoma in intracerebral hemorrhage patients.
METHODS: Four patients with unilateral putaminal hemorrhage and one patient with right thalamic hemorrhage were studied (mean +/- 1 SD age, 50.0 +/- 8.8 years). The initial volume of hematoma ranged from 4.3 to 31.0 mL (mean +/- 1 SD, 17.5 +/- 12.3 mL). SPECT images obtained 3 hours after intravenous administration of [123I]iomazenil (167 MBq/750 ng) were analyzed. In three patients, perfusion was evaluated with [123I]IMP. On SPECT images, the radioactivity ratio of the ipsilateral to the contralateral cerebral cortex (I/C ratio) or of the contralateral to the ipsilateral cerebellar hemisphere (C/I ratio) was measured.
RESULTS: The I/C ratio for iomazenil was significantly decreased compared with unity in the temporal lobe (0.84 +/- 0.08, P < .01) and the parietal lobe (0.87 +/- 0.10, P < .05), but the C/I ratio in the cerebellum (1.00 +/- 0.03) was not. The C/I ratio for perfusion in the cerebellar cortex (0.83 +/- 0.04, P < .01) was significantly decreased compared with that in normal subjects.
CONCLUSIONS: Central benzodiazepine receptor-[123I]iomazenil binding was decreased in the ipsilateral cerebral cortex remote from the subcortical hematoma. This preliminary result may facilitate further study of the potential damage of the cortical neurons remote from subcortical hematoma.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7491648     DOI: 10.1161/01.str.26.12.2267

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  8 in total

1.  Recovered neuronal viability revealed by Iodine-123-iomazenil SPECT following traumatic brain injury.

Authors:  Hiroyasu Koizumi; Hirosuke Fujisawa; Tetsu Kurokawa; Eiichi Suehiro; Hideyuki Iwanaga; Jyoji Nakagawara; Michiyasu Suzuki
Journal:  J Cereb Blood Flow Metab       Date:  2010-08-04       Impact factor: 6.200

2.  Atrophy of the corpus callosum associated with a decrease in cortical benzodiazepine receptor in large cerebral arterial occlusive diseases.

Authors:  H Yamauchi; H Fukuyama; Y Dong; H Nabatame; Y Nagahama; S Nishizawa; J Konishi; H Shio
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-03       Impact factor: 10.154

3.  Delayed image of iodine-123 iomazenil as a relative map of benzodiazepine receptor binding: the optimal scan time.

Authors:  Y Onishi; Y Yonekura; F Tanaka; S Nishizawa; H Okazawa; K Ishizu; T Fujita; J Konishi; T Mukai
Journal:  Eur J Nucl Med       Date:  1996-11

4.  Characterisation of [123I]iomazenil distribution in a rat model of focal cerebral ischaemia in relation to histopathological findings.

Authors:  Tomohito Kaji; Yuji Kuge; Chiaki Yokota; Masafumi Tagaya; Hiroyasu Inoue; Tohru Shiga; Kazuo Minematsu; Nagara Tamaki
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-10-08       Impact factor: 9.236

5.  Preoperative 123I-iomazenil SPECT imaging predicts cerebral hyperperfusion following endarterectomy for unilateral cervical internal carotid artery stenosis.

Authors:  Yasushi Ogasawara; Kuniaki Ogasawara; Taro Suzuki; Takeshi Yamashita; Hiroki Kuroda; Kohei Chida; Shunrou Fujiwara; Kenta Aso; Masakazu Kobayashi; Kenji Yoshida; Kazunori Terasaki; Akira Ogawa
Journal:  Am J Nucl Med Mol Imaging       Date:  2011-12-15

6.  Selective neuronal damage and Wisconsin Card Sorting Test performance in atherosclerotic occlusive disease of the major cerebral artery.

Authors:  Hiroshi Yamauchi; Ryuichi Nishii; Tatsuya Higashi; Shinya Kagawa; Hidenao Fukuyama
Journal:  J Neurol Neurosurg Psychiatry       Date:  2010-08-27       Impact factor: 10.154

7.  Increase in extraction of I-123 iomazenil in patients with chronic cerebral ischemia.

Authors:  Hiroki Kato; Kayako Isohashi; Eku Shimosegawa; Jun Hatazawa
Journal:  PLoS One       Date:  2018-01-11       Impact factor: 3.240

8.  Cortical Neural Damage Associated with Cerebral Hyperperfusion after Reperfusion Therapy for Acute Ischemic Stroke: 123I-iomazenil Single-photon Emission Computed Tomography Findings.

Authors:  Hiroki Kuroda; Daisuke Yamamoto; Hiroyuki Koizumi; Satoru Shimizu; Toshihiro Kumabe
Journal:  NMC Case Rep J       Date:  2021-07-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.